Zhejiang Jingxin Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Zhejiang Jingxin Pharmaceutical has a total shareholder equity of CN¥5.7B and total debt of CN¥332.0M, which brings its debt-to-equity ratio to 5.8%. Its total assets and total liabilities are CN¥8.3B and CN¥2.6B respectively. Zhejiang Jingxin Pharmaceutical's EBIT is CN¥597.6M making its interest coverage ratio -11. It has cash and short-term investments of CN¥2.2B.
Key information
5.8%
Debt to equity ratio
CN¥332.00m
Debt
Interest coverage ratio | -11x |
Cash | CN¥2.18b |
Equity | CN¥5.71b |
Total liabilities | CN¥2.62b |
Total assets | CN¥8.33b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002020's short term assets (CN¥3.7B) exceed its short term liabilities (CN¥2.2B).
Long Term Liabilities: 002020's short term assets (CN¥3.7B) exceed its long term liabilities (CN¥369.1M).
Debt to Equity History and Analysis
Debt Level: 002020 has more cash than its total debt.
Reducing Debt: 002020's debt to equity ratio has reduced from 7.1% to 5.8% over the past 5 years.
Debt Coverage: 002020's debt is well covered by operating cash flow (285.4%).
Interest Coverage: 002020 earns more interest than it pays, so coverage of interest payments is not a concern.